apomorphine has been researched along with Infusion Site Adverse Event in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Müller, T | 1 |
Borgemeester, RWK; Diercks, GFH; van Laar, T | 1 |
Nemas, M; Nyska, A; Ramot, Y; Rubinski, A; Schiffenbauer, YS; Shaltiel-Karyo, R; Tsarfati, Y; Weinstock, I; Yacoby-Zeevi, O; Zawoznik, E | 1 |
1 review(s) available for apomorphine and Infusion Site Adverse Event
Article | Year |
---|---|
An evaluation of subcutaneous apomorphine for the treatment of Parkinson's disease.
Topics: Antiparkinson Agents; Apomorphine; Disease Progression; Dopamine Agonists; Humans; Injection Site Reaction; Injections, Subcutaneous; Levodopa; Parkinson Disease; Subcutaneous Tissue | 2020 |
2 other study(ies) available for apomorphine and Infusion Site Adverse Event
Article | Year |
---|---|
Treatment of subcutaneous nodules after infusion of apomorphine; a biopsy-controlled study comparing 4 frequently used therapies.
Topics: Administration, Topical; Aged; Antiparkinson Agents; Apomorphine; Biopsy; Cross-Over Studies; Dopamine Agonists; Female; Humans; Hydrocortisone; Hypodermoclysis; Infusions, Subcutaneous; Injection Site Reaction; Male; Massage; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease; Patient Satisfaction; Prospective Studies; Skin Diseases | 2021 |
Magnetic Resonance Imaging as a Noninvasive Method for Longitudinal Monitoring of Infusion Site Reactions Following Administration of a Novel Apomorphine Formulation.
Topics: Animals; Antiparkinson Agents; Apomorphine; Biomarkers; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Injection Site Reaction; Injections, Subcutaneous; Magnetic Resonance Imaging; Male; Parkinson Disease; Swine | 2017 |